Publication | Closed Access
Low Micromolar Inhibitors of Galectin‐3 Based on 3′‐Derivatization of<i>N</i>‐Acetyllactosamine
105
Citations
25
References
2002
Year
Pharmaceutical ScienceBioorganic ChemistryGlycobiologyPolysaccharideChemical BiologyPharmaceutical ChemistryMedicinal ChemistryAromatic AmideLow Micromolar InhibitorsPotential Galectin InhibitorsInhibitory ActivityGlycosylationBiochemistryPharmacologyNatural SciencesMedicineCarbohydrate-protein InteractionDrug DiscoveryGalectin-3-blocking Pharmaceuticals
A strategy for generating potential galectin inhibitors was devised based on derivatization at the C-3' atom in 3'-amino-N-acetyllactosamine by using structural knowledge of the galectin carbohydrate recognition site. A collection of 12 compounds was prepared by N-acylations or N-sulfonylations. Hydrophobic tagging of the O-3 atom in the N-acetylglucosamine residue with a stearic ester allowed rapid and simple product purification. The compounds were screened in a galectin-3 binding assay and three compounds with significantly higher inhibitory activities compared to the parent N-acetyllactosaminide were found. These three best inhibitors all carried an aromatic amide at the C-3' position of the galactose moiety, which indicates that favorable interactions were formed between the aromatic group and galectin-3. The best inhibitor had an IC50 value (4.4 microM) about 50 times better than the parent N-acetyllactosaminide, which implies that it has potential as a valuable tool for studying galectin-3 biological functions and also as a lead compound for the development of galectin-3-blocking pharmaceuticals.
| Year | Citations | |
|---|---|---|
Page 1
Page 1